Tratamiento dopaminérgico en la enfermedad de Parkinson: ¿qué puede ofrecer cada familia terapéutica?

Pagonabarraga, Javier; Kulisevsky, Jaume.
Rev. neurol. (Ed. impr.) ; 58(1): 25-34, 1 ene., 2014. tab
Artículo en Español | IBECS (España) | ID: ibc-117853

Documentos relacionados

  1. Evolving concepts on bradykinesia.
  2. Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia.
  3. Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience.
  4. Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease.
  5. Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion-extension task in patients with Parkinson's disease.
  6. L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.
  7. [The efficacy analysis of neurosurgical robot-assisted DBS in the treatment of elderly Parkinson's disease].
  8. Dopamine agonists for the treatment of cocaine dependence.
  9. Dopamine agonists for the treatment of cocaine dependence.
  10. Non-lesional treatments for tremor in Parkinson's disease: A systematic review and meta-analysis.